BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for XOMA Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 5:19 pm Sale | 2025-01-24 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 2,983,026 25.300% | -650,717 (-17.91%) | Filing |
| 2024-01-16 5:22 pm Purchase | 2024-01-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% | 103,200 (+2.92%) | Filing |
| 2021-04-02 5:16 pm Sale | 2021-03-31 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,530,543 31.400% | -651,700 (-15.58%) | Filing |
| 2020-12-15 5:21 pm Unchanged | 2020-12-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.900% | 0 (Unchanged) | Filing |
| 2020-10-09 5:20 pm Unchanged | 2020-10-07 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% | 0 (Unchanged) | Filing |
| 2020-09-23 5:28 pm Purchase | 2020-09-21 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% | 156,086 (+3.88%) | Filing |
| 2020-04-17 4:54 pm Purchase | 2020-04-15 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,026,157 36.600% | 12,703 (+0.32%) | Filing |
| 2020-03-17 9:26 pm Purchase | 2020-03-13 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,013,454 36.400% | 118,277 (+3.04%) | Filing |
| 2020-02-13 5:30 pm Purchase | 2020-02-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,895,177 35.400% | 1,252,772 (+47.41%) | Filing |